Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
Harefuah|June 8, 2012
[Adjuvant treatment with trastuzumab in early breast cancer]Rinat Yerushalmi, Aaron SulkesHarefuah|May 23, 2002
[Rising CA-125 levels in a patient with ovarian cancer are not always indicative of disease recurrence]Rinat Yerushalmi, Erica Rakowsky, Aaron SulkesOncotarget|November 1, 2014
Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cellsAnnat Raiter, Rinat Yerushalmi, Britta HardyBMC Cancer|April 21, 2020
GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatmentAnnat Raiter, Julia Lipovetzki, Ido Lubin, et al.Oncology Letters|December 2, 2015
Cell surface GRP78: A potential marker of good prognosis and response to chemotherapy in breast cancerRinat Yerushalmi, Annat Raiter, Karen Nalbandyan, et al.European Journal of Breast Health|August 25, 2025
Role of Radiotherapy in Elderly Patients (≥65 Years) With Triple-Negative Breast Cancer: A Systematic Review and Meta-AnalysisEran Sharon, Igor Snast, Rinat Yerushalmi, et al.Clinical Breast Cancer|October 12, 2015
Breast Cancer Subtype Variation by Race and Ethnicity in a Diverse Population in British ColumbiaDante Wan, Diego Villa, Ryan Woods, et al.Oncology|September 27, 2017
Early Breast Cancer in the Elderly: Characteristics, Therapy, and Long-Term OutcomeOmer Gal, Yael Ishai, Aaron Sulkes, et al.Oncoimmunology|August 18, 2023
TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through CD45 receptorAnnat Raiter, Julia Lipovetsky, Asaf Stenbac, et al.Current Opinion in Oncology|September 2, 2021
Genetic testing in patients with triple-negative or hereditary breast cancerRinat Bernstein-Molho, Ella Evron, Rinat Yerushalmi, et al.Pageof 10